The ingredients are the same. The new national standard version of Baikaite Bai Yue has been upgraded in terms of nutritional components, adding five categories of nutritional components, namely protein, fat, carbohydrate, vitamins and minerals, among which selenium and manganese are optional components.
This means that compared with the previous version, the new version of Baikaite Bai Yue is richer and more diversified in nutrition. Such an upgrade may be to meet consumers' expectations for comprehensive nutrition and diversified nutritional needs, thus providing more comprehensive nutritional support.
Related information:
Bai Yue Bio is a company specializing in the marketing and promotion of recombinant collagen, which is jointly invested by Chuangjian Bio and Kemeiyimei Company. Now it has reached strategic cooperation with nearly 300 large and medium-sized institutions in China, covering 24 provinces across the country. Its brands include Ji, Jian and Ji.
Products are mainly distributed in skin beauty, hair transplantation, hair care and other fields. The company is headquartered in Beijing, and the team management has many years of medical background and strong professionalism.
In 2022, he won the "2022 Anti-aging Collagen Brand Trusted by Consumers" at the Magic Star Fashion Awards Ceremony of the 2nd Global Medical Beauty Consumer Star Fashion Conference; In February, 2023, 18 was awarded the best brand partner of Plastic Surgery facial make-up Committee of China Association of Non-public Medical Institutions, and Bai Yue Bio is committed to becoming a leading enterprise in the collagen industry.
Chuangjian Medical has the largest stable fermentation purification technology in China, with100000 GMP purification workshop, 2000㎡ 100-level workshop and 30 tons of fermentation. At present, it is known that the domestic recombinant collagen production enterprises have the largest fermentation volume. In 20021year, the company's total revenue reached1.200 million+,with an estimated revenue growth rate of 500% in recent five years, and it has 43 biotechnology patents.
In the whole year, R&D investment accounted for 20%, PCT application 1, 7 authorized inventions, 20 utility model patents, and more than 30 second-class medical devices with recombinant collagen were approved. 2026,5438+0, Chuangjian Medical is one of the drafting units of China's industry standard YY/T 1849 recombinant collagen (2022).